Market Place
Sourcing Support
Diabetes Institute Announces Breakthrough Transplantation For Type 1 Diabetes
24 Jun 2024 //
ACCESSWIRE
iTolerance, Inc. to Present at Biotech Showcase(TM) 2024
04 Jan 2024 //
ACCESSWIRE
iTolerance and Kadimastem Submit Initial Targeted Engagement for CBER Products
07 Nov 2023 //
ACCESSWIRE
iTolerance, Inc. to Participate at the Virtual Investor Ask the CEO Conference
11 Oct 2023 //
ACCESSWIRE
iTolerance Bolsters Global Intellectual Property with Issuance of EU Patent
18 Sep 2023 //
ACCESSWIRE
iTolerance, Northway Partner on Manufacture of Streptavidin-FasL Fusion Protein
01 Aug 2023 //
CONTRACT PHARMA
iTolerance, Inc. to Participate in the Virtual Investor Summer Spotlight Series
06 Jul 2023 //
ACCESSWIRE
iTolerance, Inc. and Kadimastem Enter into Collaboration Agreement
18 May 2023 //
ACCESSWIRE
iTolerance Announces Issuance of U.S. Patent Covering Proprietary, iTOL-100
20 Apr 2023 //
ACCESSWIRE
iTolerance, Inc. CEO to Present at the Bio LaunchPad Seminar
29 Mar 2023 //
ACCESSWIRE
iTolerance Enters into Agreement with the DRI
30 Jan 2023 //
ACCESSWIRE
iTolerance, Inc. Announces Formation of Strategic Advisory Board
23 Jan 2023 //
ACCESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.